Teva Announces Approval of Generic Evista(R) Tablets 60 mg in the United States

JERUSALEM--(Healthcare Sales & Marketing Network)--Teva Pharmaceutical Industries Ltd. (TEVA) announces the approval of the generic equivalent to Evista® (Raloxifene) Tablets, 60 mg, in the United States. Teva was first to file, making the product elig... Biopharmaceuticals, Generics, FDA, Product LaunchTeva Pharmaceutical, Evista, Raloxifene
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news